Seamus Fernandez
Stock Analyst at Guggenheim
(4.95)
# 128
Out of 4,966 analysts
411
Total ratings
65.1%
Success rate
31.2%
Average return
Main Sectors:
Stocks Rated by Seamus Fernandez
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TENX Tenax Therapeutics | Downgraded: Hold | n/a | $1.86 | - | 8 | Aug 31, 2026 | |
| AMLX Amylyx Pharmaceuticals | Rated: Buy | $55 → $57 | $31.62 | +80.27% | 11 | Aug 26, 2026 | |
| RYTM Rhythm Pharmaceuticals | Reiterated: Buy | $143 | $104.00 | +37.50% | 15 | Aug 24, 2026 | |
| MLYS Mineralys Therapeutics | Reiterated: Buy | $48 → $52 | $29.34 | +77.23% | 9 | Aug 12, 2026 | |
| SGMT Sagimet Biosciences | Reiterated: Buy | $25 | $10.88 | +129.78% | 5 | Aug 12, 2026 | |
| SEPN Septerna | Reiterated: Buy | $45 → $51 | $38.51 | +32.43% | 3 | Aug 11, 2026 | |
| ARCT Arcturus Therapeutics Holdings | Reiterated: Hold | n/a | $14.73 | - | 11 | Aug 6, 2026 | |
| ARQT Arcutis Biotherapeutics | Rated: Buy | $35 → $38 | $23.89 | +59.10% | 15 | Aug 5, 2026 | |
| PCVX Vaxcyte | Reiterated: Buy | $116 | $59.47 | +95.06% | 14 | Aug 5, 2026 | |
| BMY Bristol-Myers Squibb Company | Reiterated: Buy | $72 → $75 | $63.64 | +17.85% | 50 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $88 | $59.02 | +49.10% | 15 | Jul 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $1,235 → $1,273 | $1,115.70 | +14.10% | 62 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 16,500p → 16,200p | 11,708p | +38.37% | 20 | Jul 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $42.77 | - | 13 | Jul 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $15.72 | +90.84% | 3 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $4.02 | +173.63% | 6 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $5.26 | +128.35% | 4 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $140 | $38.66 | +262.13% | 7 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €110.00 → €101.00 | €73.26 | +37.87% | 10 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $43.07 | n/a | 10 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.27 | n/a | 12 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1,770.50 | n/a | 5 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $48.13 | n/a | 5 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $125 → $130 | $143.93 | n/a | 36 | Jan 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $250 → $83 | $24.14 | n/a | 5 | Oct 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.7855 | n/a | 2 | Dec 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $131.45 | n/a | 1 | Dec 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $112.04 | n/a | 4 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $137.16 | n/a | 16 | Oct 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $3.58 | n/a | 1 | Oct 17, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $3.65 | n/a | 2 | Sep 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $37 | $27.72 | n/a | 16 | Sep 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $108 | $13.34 | n/a | 1 | Aug 24, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $52 | $7.97 | n/a | 3 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $248.68 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $377.35 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $781.49 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $125 | $265.58 | n/a | 2 | Jun 14, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $56 | $33.60 | n/a | 5 | Jun 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4 | $36.90 | n/a | 1 | Mar 7, 2016 |
Tenax Therapeutics
Aug 31, 2026
Downgraded: Hold
Price Target: n/a
Current: $1.86
Upside: -
Amylyx Pharmaceuticals
Aug 26, 2026
Rated: Buy
Price Target: $55 → $57
Current: $31.62
Upside: +80.27%
Rhythm Pharmaceuticals
Aug 24, 2026
Reiterated: Buy
Price Target: $143
Current: $104.00
Upside: +37.50%
Mineralys Therapeutics
Aug 12, 2026
Reiterated: Buy
Price Target: $48 → $52
Current: $29.34
Upside: +77.23%
Sagimet Biosciences
Aug 12, 2026
Reiterated: Buy
Price Target: $25
Current: $10.88
Upside: +129.78%
Septerna
Aug 11, 2026
Reiterated: Buy
Price Target: $45 → $51
Current: $38.51
Upside: +32.43%
Arcturus Therapeutics Holdings
Aug 6, 2026
Reiterated: Hold
Price Target: n/a
Current: $14.73
Upside: -
Arcutis Biotherapeutics
Aug 5, 2026
Rated: Buy
Price Target: $35 → $38
Current: $23.89
Upside: +59.10%
Vaxcyte
Aug 5, 2026
Reiterated: Buy
Price Target: $116
Current: $59.47
Upside: +95.06%
Bristol-Myers Squibb Company
Jul 31, 2026
Reiterated: Buy
Price Target: $72 → $75
Current: $63.64
Upside: +17.85%
Jul 14, 2026
Reiterated: Buy
Price Target: $88
Current: $59.02
Upside: +49.10%
Jul 13, 2026
Rated: Buy
Price Target: $1,235 → $1,273
Current: $1,115.70
Upside: +14.10%
Jul 9, 2026
Reiterated: Buy
Price Target: 16,500p → 16,200p
Current: 11,708p
Upside: +38.37%
Jul 9, 2026
Reiterated: Hold
Price Target: n/a
Current: $42.77
Upside: -
Jun 24, 2026
Reiterated: Buy
Price Target: $30
Current: $15.72
Upside: +90.84%
May 27, 2026
Reiterated: Buy
Price Target: $11
Current: $4.02
Upside: +173.63%
May 11, 2026
Reiterated: Buy
Price Target: $12
Current: $5.26
Upside: +128.35%
May 7, 2026
Reiterated: Buy
Price Target: $140
Current: $38.66
Upside: +262.13%
Oct 8, 2025
Reiterated: Buy
Price Target: €110.00 → €101.00
Current: €73.26
Upside: +37.87%
Apr 17, 2025
Downgraded: Hold
Price Target: n/a
Current: $43.07
Upside: n/a
Apr 3, 2025
Rated: Hold
Price Target: n/a
Current: $3.27
Upside: n/a
Oct 31, 2024
Downgraded: Hold
Price Target: n/a
Current: $1,770.50
Upside: n/a
Oct 31, 2024
Downgraded: Hold
Price Target: n/a
Current: $48.13
Upside: n/a
Jan 29, 2024
Reiterated: Buy
Price Target: $125 → $130
Current: $143.93
Upside: n/a
Oct 14, 2022
Reiterated: Buy
Price Target: $250 → $83
Current: $24.14
Upside: n/a
Dec 15, 2021
Downgraded: Hold
Price Target: n/a
Current: $0.7855
Upside: n/a
Dec 7, 2021
Downgraded: Hold
Price Target: n/a
Current: $131.45
Upside: n/a
Feb 25, 2020
Downgraded: Hold
Price Target: n/a
Current: $112.04
Upside: n/a
Oct 8, 2018
Initiated Coverage: Hold
Price Target: n/a
Current: $137.16
Upside: n/a
Oct 17, 2017
Initiated Coverage: Buy
Price Target: $13
Current: $3.58
Upside: n/a
Sep 20, 2016
Reiterated: Buy
Price Target: n/a
Current: $3.65
Upside: n/a
Sep 8, 2016
Reiterated: Hold
Price Target: $37
Current: $27.72
Upside: n/a
Aug 24, 2016
Reiterated: Buy
Price Target: $108
Current: $13.34
Upside: n/a
Aug 9, 2016
Reiterated: Buy
Price Target: $52
Current: $7.97
Upside: n/a
Jul 15, 2016
Rated: Buy
Price Target: n/a
Current: $248.68
Upside: n/a
Jul 15, 2016
Rated: Hold
Price Target: n/a
Current: $377.35
Upside: n/a
Jul 15, 2016
Rated: Buy
Price Target: n/a
Current: $781.49
Upside: n/a
Jun 14, 2016
Reiterated: Buy
Price Target: $125
Current: $265.58
Upside: n/a
Jun 13, 2016
Reiterated: Hold
Price Target: $56
Current: $33.60
Upside: n/a
Mar 7, 2016
Downgraded: Hold
Price Target: $4
Current: $36.90
Upside: n/a